Evidence map›Paper›PMID 24530523›Full record

ReviewGeneral and comparative endocrinology2014

Current concepts in neuroendocrine disruption.

Martha León-Olea, Christopher J Martyniuk, Edward F Orlando, Mary Ann Ottinger, Cheryl Rosenfeld, Jennifer Wolstenholme, Vance L Trudeau

Open access · greenAbstract readReview
In one paragraph

Review in General and comparative endocrinology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 45 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
45citing papers in PubMed, 1 pooled it
9.6field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

45 citing papers in PubMed, 1 synthesis or guideline pooled it, 134 citations in OpenAlex.

  1. Pooled it
  2. Immunomodulatory Effects ofPharmaceuticals (Basel, Switzerland) · 2025
    Article
  3. Article
  4. Review
  5. Article
  6. Review
  7. Article
  8. Review
  9. Review
  10. Review
  11. Article
  12. An Ethanolic Extract ofFrontiers in pharmacology · 2021
    Article
  13. Review
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 7 institutions in 3 countries.

Martha León-Olea *Departamento de Neuromorfología Funcional, Dirección de Investigaciones en Neurociencias, Instituto Nacional de Psiquiatría, R.F.M., México D.F., México.
Christopher J Martyniuk *Canadian Rivers Institute and Department of Biology, University of New Brunswick, Saint John, New Brunswick, E2L 4L5, Canada.
Edward F Orlando *University of Maryland, Department of Animal and Avian Sciences, College Park, MD 20742, USA.
Mary Ann Ottinger *University of Maryland, Department of Animal and Avian Sciences, College Park, MD 20742, USA.
Cheryl Rosenfeld *Departments of Biomedical Sciences and Bond Life Sciences Center, Genetics Area Program, University of Missouri, Columbia, MO 65211, USA.
Jennifer Wolstenholme *Department of Biochemistry and Molecular Genetics, University of Virginia, Charlottesville, VA 23112, USA.
Vance L Trudeau *Department of Biology, University of Ottawa, 30 Marie Curie Private, Ottawa, ON, Canada, K1N 6N5.
Instituto Nacional de Psiquiatría · MXUniversity of Houston · USUniversity of Maryland, College Park · USUniversity of Missouri · USUniversity of New Brunswick · CAUniversity of Ottawa · CAUniversity of Virginia · US

Funding

Effects of In Utero and Transgenerational Exposure of Avy Mice to Bisphenol ARC1ES018195 · NIEHS · UNIVERSITY OF MISSOURI-COLUMBIA · PI ROSENFELD, CHERYL SUSAN · 2009 to 2010
$990k
Neurobehavioral effects of Bisphenol A Across age and sexU01ES020929 · NIEHS · NORTH CAROLINA STATE UNIVERSITY RALEIGH · PI PATISAUL, HEATHER B, ROSENFELD, CHERYL SUSAN · 2011 to 2014
$775k
Epigenetic and Behavioral Effects of BPA ExposureF32ES019404 · NIEHS · UNIVERSITY OF VIRGINIA · PI WOLSTENHOLME, JENNIFER T · 2011 to 2013
$168k
NIEHS NIH HHS F32 ES019404NIEHS NIH HHS RC1 ES018195NIEHS NIH HHS U01 ES020929
6 · The paper itself

Abstract

In the last few years, it has become clear that a wide variety of environmental contaminants have specific effects on neuroendocrine systems in fish, amphibians, birds and mammals. While it is beyond the scope of this review to provide a comprehensive examination of all of these neuroendocrine disruptors, we will focus on select representative examples. Organochlorine pesticides bioaccumulate in neuroendocrine areas of the brain that directly regulate GnRH neurons, thereby altering the expression of genes downstream of GnRH signaling. Organochlorine pesticides can also agonize or antagonize hormone receptors, adversely affecting crosstalk between neurotransmitter systems. The impacts of polychlorinated biphenyls are varied and in many cases subtle. This is particularly true for neuroedocrine and behavioral effects of exposure. These effects impact sexual differentiation of the hypothalamic-pituitary-gonadal axis, and other neuroendocrine systems regulating the thyroid, metabolic, and stress axes and their physiological responses. Weakly estrogenic and anti-androgenic pollutants such as bisphenol A, phthalates, phytochemicals, and the fungicide vinclozolin can lead to severe and widespread neuroendocrine disruptions in discrete brain regions, including the hippocampus, amygdala, and hypothalamus, resulting in behavioral changes in a wide range of species. Behavioral features that have been shown to be affected by one or more these chemicals include cognitive deficits, heightened anxiety or anxiety-like, sociosexual, locomotor, and appetitive behaviors. Neuroactive pharmaceuticals are now widely detected in aquatic environments and water supplies through the release of wastewater treatment plant effluents. The antidepressant fluoxetine is one such pharmaceutical neuroendocrine disruptor. Fluoxetine is a selective serotonin reuptake inhibitor that can affect multiple neuroendocrine pathways and behavioral circuits, including disruptive effects on reproduction and feeding in fish. There is growing evidence for the association between environmental contaminant exposures and diseases with strong neuroendocrine components, for example decreased fecundity, neurodegeneration, and cardiac disease. It is critical to consider the timing of exposures of neuroendocrine disruptors because embryonic stages of central nervous system development are exquisitely sensitive to adverse effects. There is also evidence for epigenetic and transgenerational neuroendocrine disrupting effects of some pollutants. We must now consider the impacts of neuroendocrine disruptors on reproduction, development, growth and behaviors, and the population consequences for evolutionary change in an increasingly contaminated world. This review examines the evidence to date that various so-called neuroendocrine disruptors can induce such effects often at environmentally-relevant concentrations.

Indexed as

AnimalsEndocrine DisruptorsEnvironmental PollutantsEpigenesis, GeneticNeurosecretory SystemsPesticidesReproductionVertebratesEndocrine DisruptorsEnvironmental PollutantsPesticidesBisphenol AGrowthOrganochlorine pesticidesPharmaceuticalsPolychlorinated biphenylsReproduction

Identifiers

PMID24530523
PMCPMC4133337
OpenAlexW2006154352

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.